Targeting RNA-Protein Interactions within the Human Immunodeficiency Virus Type 1 Lifecycle

被引:31
作者
Bell, Neil M. [1 ,2 ]
L'Hernault, Anne [2 ]
Murat, Pierre [1 ]
Richards, James E. [2 ]
Lever, Andrew M. L. [2 ]
Balasubramanian, Shankar [1 ,3 ]
机构
[1] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[2] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England
[3] Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England
基金
英国医学研究理事会;
关键词
HIV-1 PACKAGING SIGNAL; GAG; INHIBITOR; BINDING; SITE; 33258-HOECHST; GLYCOPROTEIN; REQUIREMENT; ENTRY; LOOP;
D O I
10.1021/bi401270d
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA-protein interactions are vital throughout the HIV-1 life cycle for the successful production of infectious virus particles. One such essential RNA-protein interaction occurs between the full-length genomic viral RNA and the major structural protein of the virus. The initial interaction is between the Gag polyprotein and the viral RNA packaging signal (psi or Psi), a highly conserved RNA structural element within the 5'-UTR of the HIV-1 genome, which has gained attention as a potential therapeutic target. Here, we report the application of a target-based assay to identify small molecules, which modulate the interaction between Gag and Psi. We then demonstrate that one such molecule exhibits potent inhibitory activity in a viral replication assay. The mode of binding of the lead molecules to the RNA target was characterized by H-1 NMR spectroscopy.
引用
收藏
页码:9269 / 9274
页数:6
相关论文
共 37 条
[1]   A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon [J].
Abbink, TEM ;
Berkhout, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11601-11611
[3]   Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of Vif for optimal infectivity: functional difference between Vif and Nef [J].
Akari, H ;
Uchiyama, T ;
Fukumori, T ;
Iida, S ;
Koyama, AH ;
Adachi, A .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :2945-2949
[4]   HIV Gag polyprotein: processing and early viral particle assembly [J].
Bell, Neil M. ;
Lever, Andrew M. L. .
TRENDS IN MICROBIOLOGY, 2013, 21 (03) :136-144
[5]   Comparative Structural Effects of HIV-1 Gag and Nucleocapsid Proteins in Binding to and Unwinding of the Viral RNA Packaging Signal [J].
Bell, Neil M. ;
Kenyon, Julia C. ;
Balasubramanian, Shankar ;
Lever, Andrew M. L. .
BIOCHEMISTRY, 2012, 51 (15) :3162-3169
[6]   Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 [J].
Blair, Wade S. ;
Cao, Joan ;
Jackson, Lynn ;
Jimenez, Judith ;
Peng, Qinghai ;
Wu, Hua ;
Isaacson, Jason ;
Butler, Scott L. ;
Chu, Alex ;
Graham, Joanne ;
Malfait, Anne-Marie ;
Tortorella, Micky ;
Patick, Amy K. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (10) :3554-3561
[7]   ANTIVIRAL PROPERTIES OF RO 31-8959, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PROTEINASE [J].
CRAIG, JC ;
DUNCAN, IB ;
HOCKLEY, D ;
GRIEF, C ;
ROBERTS, NA ;
MILLS, JS .
ANTIVIRAL RESEARCH, 1991, 16 (04) :295-305
[8]   Structure of the HIV-1 nucleocapsid protein bound to the SL3 Ψ-RNA recognition element [J].
De Guzman, RN ;
Wu, ZR ;
Stalling, CC ;
Pappalardo, L ;
Borer, PN ;
Summers, MF .
SCIENCE, 1998, 279 (5349) :384-388
[9]   3-DIMENSIONAL STRUCTURE-ACTIVITY ANALYSIS OF A SERIES OF PORPHYRIN DERIVATIVES WITH ANTI-HIV-1 ACTIVITY TARGETED TO THE V3 LOOP OF THE GP120 ENVELOPE GLYCOPROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
DEBNATH, AK ;
JIANG, S ;
STRICK, N ;
LIN, K ;
HABERFIELD, P ;
NEURATH, AR .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (08) :1099-1108
[10]   Two alternating structures of the HIV-1 leader RNA [J].
Huthoff, H ;
Berkhout, B .
RNA, 2001, 7 (01) :143-157